Patent · US Active

Isolated laminin-421

US9534038B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

BioLamina AB · SE

Inventors

Karl Tryggvason · Stockholm, SE
Sergey Rodin · Stockholm, SE

Key dates

Filing date	Mar 1, 2012
Grant date	Jan 3, 2017
Priority date	—
Expiry date	Mar 1, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/43
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides isolated laminin-421, methods for making recombinant laminin-421, and host cells that express recombinant laminin-421. The present disclosure also provides nucleic acid sequences encoding full length human laminin β2 chain, expression vectors and host cells thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.